James Sapirstein

James Sapirstein

Chief Executive Officer at FIRST WAVE BIOPHARMA, INC.

Net worth: 162 581 $ as of 2024-03-30

63 year
Health Technology
Commercial Services
Consumer Services

Profile

Mr. James E. Sapirstein is a Chairman & Chief Executive Officer at AzurRx BioPharma, Inc., a Chairman & Chief Executive Officer at Marizyme, Inc., an Independent Director at Enochian Biosciences, Inc., a Director & Member-Emerging Companies at Biotechnology Innovation Organization and an Independent Director at Blue Water Acquisition Corp. He is on the Board of Directors at Enochian Biosciences, Inc., Leading Biosciences, Inc., Biotechnology Innovation Organization, BioNJ, Inc., Clinical Supplies Management, Inc. and Blue Water Acquisition Corp. Mr. Sapirstein was previously employed as an Independent Director by NanoViricides, Inc., an Independent Director by Panther Biotechnology, Inc., an Independent Director by RespireRx Pharmaceuticals, Inc., a Chief Executive Officer & Director by ContraVir Pharmaceuticals, Inc., a Chief Executive Officer & Director by Alliqua, Inc., a President, Chief Executive Officer & Director by Tobira Therapeutics, Inc. /Old/, an Executive Vice President-Metabolic & Endocrinology by Serono, Inc., a Global Marketing Lead by Gilead Sciences, Inc., a Director-International Marketing by Bristol Myers Squibb Co., a Principal by Eli Lilly & Co., and a Product Director by Hoffmann-La Roche, Inc. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Fairleigh Dickinson University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-03-31 37,105 ( 1.83% ) 162 520 $ 2024-03-30
2023-10-15 14 ( inf% ) 61 $ 2024-03-30
2024-04-04 0 ( -.--% ) - $ 2024-03-30
2024-03-05 0 ( -.--% ) - $ 2024-03-30

James Sapirstein active positions

CompaniesPositionStart
RENOVARO INC. Director/Board Member 2018-03-05
FIRST WAVE BIOPHARMA, INC. Chief Executive Officer 2019-10-07
ZYVERSA THERAPEUTICS, INC. Director/Board Member 2023-01-04
ONCONETIX, INC. Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member 2016-02-29
Director/Board Member 2015-06-15
All active positions of James Sapirstein

Former positions of James Sapirstein

CompaniesPositionEnd
MARIZYME, INC. Chief Executive Officer 2021-06-23
░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of James Sapirstein's experience

Training of James Sapirstein

Rutgers State University of New Jersey Undergraduate Degree
Fairleigh Dickinson University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Sapirstein's experience

Connections

100 +

1st degree connections

26

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies12
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

GILEAD SCIENCES, INC.

Health Technology

ELI LILLY AND COMPANY

Health Technology

RESPIRERX PHARMACEUTICALS INC.

Health Technology

RENOVARO INC.

Health Technology

PROBILITY MEDIA CORPORATION

Commercial Services

HEPION PHARMACEUTICALS, INC.

Health Technology

NANOVIRICIDES, INC.

Health Technology

MARIZYME, INC.

Health Technology

FIRST WAVE BIOPHARMA, INC.

Health Technology

ZYVERSA THERAPEUTICS, INC.

Health Technology

ONCONETIX, INC.

Health Technology

Private companies12

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Health Technology

Finance

Finance

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. James Sapirstein